본문 바로가기
bar_progress

Text Size

Close

SkinRx Lab's 'Madecera Cream' Surpasses 10 Billion KRW in Cumulative Sales

SkinRx Lab's 'Madecera Cream' Surpasses 10 Billion KRW in Cumulative Sales


[Asia Economy Reporter Seungjin Lee] SkinRx Lab announced on the 5th that its ‘MadeCera Cream’ has surpassed 10 billion KRW in global cumulative sales.


SkinRx Lab’s flagship product, ‘MadeCera Cream,’ is a moisturizing cream that quickly soothes sensitive skin with MadeCera ingredients developed in SkinRx Lab’s unique formula ratio.


The patented technology 'Pre-Lipid' encapsulates ceramides in hundreds of millions of liposomes to deliver them deep into the skin for rapid effect. Niacinamide, a whitening functional ingredient, brightens the skin tone, and adenosine, effective for wrinkle improvement, helps with skin elasticity. The product has completed skin irritation tests and suitability tests for acne-prone skin.


A SkinRx Lab representative said, “We are grateful that ‘MadeCera Cream’ is loved by many customers through various domestic and international distribution channels such as Olive Young, Watsons, and 7-Eleven,” adding, “Based on the excellent product power of MadeCera Cream, we are developing products to address various skin concerns.”


Meanwhile, to celebrate surpassing 10 billion KRW in cumulative sales, SkinRx Lab is holding a uniform price sale offering ‘MadeCera Cream’ and some other items for 9,900 KRW. This event runs until the end of October and purchases can be made on the SkinRx Lab official website.

This content was produced with the assistance of AI translation services.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


Join us on social!

Top